Home LiteratureArticle Details
PMID: 16557817 Published · ppublish English Journal Article

Prevention of experimental hematogenous and retrograde pyelonephritis by antibodies against enterobacterial common antigen.

Infection and immunity ·Vol. 2 ·No. 2 ·1970-08-00 ·Pages 175-82

Domingue G, Salhi A, Rountree C, Little W

Abstract

Rabbits were immunized with common antigen (CA) derived from Salmonella typhimurium. Animals with CA hemagglutinin titers of 1-320 to 1-81,920 were injected with 10(7) viable Proteus mirabilis via the retrograde and hematogenous routes. Nonimmune control groups were challenged similarly. From the retrogradely challenged groups sacrificed at 4 weeks, pyelonephritis was found in 89% of the control animals but not in those immunized. Bacteriuria was present in 89% of the controls but in only 61% of the immunized group. Hematogenously challenged, immune animals sacrificed at 6 weeks did not show histological evidence of renal pathology, and only 6% had bacteriuria. Eighty-six per cent of the nonimmune controls showed both pyelonephritis and bacteriuria. The protective effect is specific because of the following. (i) Active and passive CA immunization did not prevent pyelonephritis due to Pseudomonas aeruginosa which does not produce this antigen. (ii) Passive immunization with a CA antiserum conferred protection against a P. mirabilis challenge. (iii) Passive administration of an antiserum from which CA antibodies had been differentially absorbed abolished the protective activity.

Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Domingue G
Tulane University School of Medicine, Department of Surgery, Section of Urology, and Department of Microbiology and Immunology, New Orleans, Louisiana 70112.
Salhi A
Rountree C
Little W
References (11)
11 references, click to expand
  1. The plaque test for the demonstration of antibodies against the enterobacterial common antigen produced by spleen and lymph node cells.
    Immunology. 1967 Dec;13(6):539-45 PMID: 4863728
  2. Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae.
    J Bacteriol. 1966 Jan;91(1):129-33 PMID: 4955466
  3. Inhibition by lipoid A of formation of antibodies against common antigen of enterobacteriaceae.
    Proc Soc Exp Biol Med. 1965 Nov;120(2):371-4 PMID: 5323094
  4. Inhibition by lipopolysaccharide of immune phagocytosis of latex particles modified with common antigen of enteric bacteria.
    Proc Soc Exp Biol Med. 1966 Jan;121(1):133-7 PMID: 5323235
  5. "Active" chronic pyelonephritis without evidence of bacterial infection.
    N Engl J Med. 1968 Jun 13;278(24):1303-8 PMID: 5648595
  6. Antibody response to the common enterobacterial antigen of children with shigellosis, salmonellosis or urinary tract infection.
    Am J Med Sci. 1968 Jul;256(1):18-24 PMID: 5664328
  7. Etiology of pyelonephritis: intraductal crystallization as a co-factor.
    J Urol. 1969 Jun;101(6):786-90 PMID: 5771244
  8. STUDY OF HETEROGENETIC (KUNIN) ANTIBODIES IN SERUM OF HEALTHY SUBJECTS AND CHILDREN WITH ENTERIC AND URINARY TRACT INFECTIONS.
    J Pediatr. 1963 Sep;63:412-9 PMID: 14065338
  9. SEPARATION BY ETHANOL OF COMMON AND SOMATIC ANTIGENS OF ENTEROBACTERIACEAE.
    J Bacteriol. 1964 Nov;88:1240-3 PMID: 14234776
  10. INHIBITION BY LIPOPOLYSACCHARIDE (ENDOTOXIN) OF ANTIBODY RESPONSE OF RABBIT TO COMMON ANTIGEN OF ENTEROBACTERIACEAE.
    Proc Soc Exp Biol Med. 1964 Dec;117:785-9 PMID: 14244955
  11. The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis.
    J Exp Med. 1962 Feb 1;115:383-410 PMID: 14496914
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1970-08-00
Pages
175-82
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC415986
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com